glp 1 analogue weight loss glp-1_analogs [TUSOM GLP-1 Agonists: Using Semaglutide, Tirzepatide,

Strengths Acts via multiple pathways (GLP-1, AMPK, microbiome) Has existing human data showing reductions in fasting glucose, HbA1c, lipids Support receptor expression and islet health Limitations Low absorption and bioavailability Gastrointestinal discomfort is common (diarrhea, cramping)

While positive for consumers, it places significant financial pressure on an already brittle healthcare and Medicare ecosystem

Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials.

This is evidenced by up-regulation of glycolytic enzyme expression, increased rates of glucose uptake and consumption, as well as augmented ATP content, insulin secretion and glycolytic flux after removal of Exendin-4

Do not apply heat directly over the patch

Remove the patch, fold in half, and discard